SEC Contract Filing

Filing Date: 2019-05-08

Document Content:
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>ex104.htm
<DESCRIPTION>EX-10.4
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>BECAUSE HORIZON THERAPEUTICS PLC HAS DETERMINED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>THE INFORMATION (I)&nbsp;IS NOT MATERIAL AND (II)&nbsp;WOULD </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>LIKELY CAUSE COMPETITIVE HARM TO HORIZON </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>THERAPEUTICS PLC IF PUBLICLY DISCLOSED. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMMERCIAL SUPPLY AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(DRUG PRODUCT) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS COMMERCIAL SUPPLY
AGREEMENT (this &#147;<B>Agreement</B>&#148;) is entered into and effective this 18th day of November, 2018 (&#147;<B>Effective Date</B>&#148;) by and between <B>Catalent Indiana, LLC</B> (&#147;<B>Catalent</B>&#148;), an Indiana limited liability
company with offices at 1300 South Patterson Drive, Bloomington, Indiana 47403, and <B>Horizon Pharma Ireland Limited</B> (&#147;<B>Client</B>&#148;), a company incorporated under the laws of Ireland with offices at Connaught House, 1 Burlington
Road, Dublin 4, Ireland. In this Agreement, Catalent and Client each may be referred to individually as a &#147;<B>Party</B>&#148; and together as &#147;<B>Parties</B>.&#148; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHEREAS, Catalent is a leading
provider of advanced technologies, and development, manufacturing and packaging services, for pharmaceutical, biotechnology and consumer healthcare companies; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHEREAS, Client develops, markets and sells pharmaceutical products; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHEREAS, Client is the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">successor-in-interest</FONT></FONT> to River Vision Development Corp.
(&#147;<B>River Vision</B>&#148;) and Catalent is the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">successor-in-interest</FONT></FONT> to Cook Pharmica LLC (&#147;<B>Cook</B>&#148;) under that certain Commercial Supply Agreement
between River Vision and Cook dated July&nbsp;7, 2016 (the &#147;<B>Prior CSA</B>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHEREAS, Client desires to have Catalent provide the Services
(as defined below) set forth in this Agreement and any Plan (as defined below), and Catalent desires to provide such Services, all pursuant to the terms and conditions in this Agreement; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties intend that this Agreement supersede and replace the Prior CSA as of the Effective Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein, the Parties agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Definitions. </B>For purposes of this Agreement, the following terms will have the meanings set forth below:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>1.1</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>&#147;<B>Affiliate</B>&#148; means, (a)&nbsp;with respect to Client or any third party, corporation,
firm, partnership or other entity that directly or indirectly controls, is controlled by or is under common control with such entity; and (b)&nbsp;with respect to Catalent, Catalent, Inc. and any corporation, firm, partnership or other entity
controlled by Catalent, Inc. For the purposes of this definition, &#147;control&#148; means the ownership of at least 50% of the voting share cap